USPTO serial 79347652
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Acai powder dietary supplements; acaricides; acne treatment preparations; adhesive tapes for medical purposes; adhesives for dentures; adjuvants for medical purposes; air purifying preparations; albumin dietary supplements; alcohol for pharmaceutical purposes; algicides; alginate dietary supplements; alginates for pharmaceutical purposes; alloys of precious metals for dental purposes; almond milk for pharmaceutical purposes; aloe vera preparations for pharmaceutical purposes; aluminium acetate for pharmaceutical purposes; amino acids for medical purposes; anesthetics; analgesics; angostura bark for medical purposes; anti-inflammatories; anti-uric preparations; antibacterial handwashes; antibacterial soap; antibiotics; anticryptogamis preparations; antiparasitic preparations; antiseptic cotton; antiseptics; appetite suppressant pills; appetite suppressants for medical purposes; aromatic deodorizers for toilets; aseptic cotton; asthmatic tea; astringents for medical purposes; bacterial poisons; balms for medical purposes; balsamic preparations for medical purposes; bandages for dressings; bath preparations for medical purposes; bath salts for medical purposes; bicarbonate of soda for pharmaceutical purposes; biocides; biological tissue cultures for medical purposes; bismuth preparations for pharmaceutical purposes; bismuth subnitrate for pharmaceutical purposes; blood for medical purposes; blood plasma; bone void fillers comprised of living tissues; brewer's yeast dietary supplements; bromine for pharmaceutical purposes; bronchodilators; bunion pads; by-products of the processing of cereals for dietetic or medical purposes; camphor for medical purposes; casein dietary supplements; caustic pencils; caustics for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; charcoal for pharmaceutical purposes; chemical contraceptives; chewing gum for medical purposes; chinoline for medical purposes; cod liver oil; collagen for medical purposes; collodion for pharmaceutical purposes; contact lens cleaning preparations; contraceptive sponges; cotton for medical purposes; cream of tartar for pharmaceutical purposes; dental abrasives; dental amalgams; dental amalgams of gold; dental cements; dental impression materials; dental laquer; dental mastics; detergents for medical purposes; deodorants for clothing and textiles; diagnostic preparations for medical purposes; dietary supplements with a cosmetic effect; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; digestives for pharmaceutical purposes; disinfectant soap; disinfectants; disinfectants for hygienic purposes; douching preparations for medical purposes; enzyme dietary supplements; enzyme preparations for medical purposes; extract of hops for pharmaceutical purposes; eyepatches for medical purposes; ferments for pharmaceutical purposes; flowers of sulfur for pharmaceutical purposes; gallic acid for pharmaceutical purposes; gases for medical purposes; glucose dietary supplements; glycerine for medical purposes; herbal extracts for medical purposes; hydrated chloral for pharmaceutical purposes; hydrogen peroxide for medical purposes; injectable dermal fillers; jujube, medicated; laxatives; lecithin dietary supplements; leeches for medical purposes; ointments; liquorice for pharmaceutical purposes; malt for pharmaceutical purposes; malted milk beverages for medical purposes; massage candles for therapeutic purposes; massage gels for medical purposes; medical preparations for slimming purposes; medicated after-shave lotions; medicated dry shampoos; medicated eye-washes; medicated hair lotions; medicated shampoos; medicated soap; medicated toothpaste; medicinal alcohol; medicinal drinks; medicinal hair growth preparations; medicinal herbs; medicinal oils; medicinal tea; medicines for dental purposes; melissa water for pharmaceutical purposes; mineral dietary supplements; mineral waters for medical purposes; mint for pharmaceutical purposes; nicotine gum for use as an aid to stop smoking; pearl powder for medical purposes; pediculicidal shampoos; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for treating sunburn; phytotherapy preparations for medical purposes; pollen dietary supplements; pomades for medical purposes; porcelain for dental prostheses; powdered milk for babies; propolis dietary supplements; propolis for pharmaceutical purposes; protein dietary supplements; royal jelly dietary supplements; royal jelly for pharmaceutical purposes; rubber for dental purposes; seawater for medicinal bathing; sexual stimulant gels; personal sexual lubricants; slimming pills; smelling salts; stick liquorice for pharmaceutical purposes; sunburn ointments; suppositories; thermal water; vaginal washes for medical purposes; vitamin preparations; vitamin supplement patches; wheat germ dietary supplements; whey protein dietary supplements; yeast dietary supplements; yeast for pharmaceutical purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 31, 2024 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 12, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 11, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 18, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 26, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 24, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 10, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 10, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 10, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 26, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 26, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 29, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 28, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 30, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 26, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 25, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 18, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |